ALNY - Alnylam Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts13131617
Avg. Estimate-1.5-1.77-6.94-5.58
Low Estimate-1.95-2.01-8.04-7.82
High Estimate-1.05-1.35-5.54-3.75
Year Ago EPS-1.25-1.34-5.42-6.94
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts11111718
Avg. Estimate30.15M22.77M124.21M340.49M
Low EstimateN/A2.5M13M177.9M
High Estimate67.93M50M176.31M598.37M
Year Ago Sales18.96M15.93M89.91M124.21M
Sales Growth (year/est)59.00%42.90%38.10%174.10%
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.-1.26-1.22-1.26-1.39
EPS Actual-1.25-1.34-1.34-1.48
Difference0.01-0.12-0.08-0.09
Surprise %0.80%-9.80%-6.30%-6.50%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate-1.5-1.77-6.94-5.58
7 Days Ago-1.5-1.77-6.94-5.57
30 Days Ago-1.43-1.76-6.72-5.02
60 Days Ago-1.44-1.78-6.57-4.17
90 Days Ago-1.36-1.58-5.51-2.9
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/A1
Up Last 30 DaysN/AN/AN/A2
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/A11
Growth EstimatesALNYIndustrySectorS&P 500
Current Qtr.-20.00%N/AN/A0.42
Next Qtr.-32.10%N/AN/A0.38
Current Year-28.00%N/AN/A0.20
Next Year19.60%N/AN/A0.10
Next 5 Years (per annum)46.09%N/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A